Goh, X. N., Seng, M. S., Loh, A. H. P., Gupta, A., Chang, K. T. E., & Iyer, P. (2021). Larotrectinib followed by selitrectinib in a novel DCTN1-NTRK1 fusion undifferentiated pleomorphic sarcoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 27(2), p. 485. doi:10.1177/1078155220938849
Chicago ZitierstilGoh, Xue Na, Michaela Su-Fern Seng, Amos Hong Pheng Loh, Achint Gupta, Kenneth Tou En Chang, and Prasad Iyer. "Larotrectinib Followed By Selitrectinib in a Novel DCTN1-NTRK1 Fusion Undifferentiated Pleomorphic Sarcoma." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 27, no. 2 (2021): 485.
MLA ZitierstilGoh, Xue Na, et al. "Larotrectinib Followed By Selitrectinib in a Novel DCTN1-NTRK1 Fusion Undifferentiated Pleomorphic Sarcoma." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 27.2 (2021): 485.